|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.040 USD | -0.98% |
|
+10.87% | -16.39% |
| 05-15 | Fortress Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 04-21 | Journey Medical Corporation secures contract with third major GPO for Emrosi | RE |
| Market Cap | 102M 87.98M 80.89M 76.13M 143M 9.62B 144M 959M 373M 4.72B 383M 375M 16.34B | P/E 2026 * |
1.28x | P/E 2027 * | 6.08x |
|---|---|---|---|---|---|
| Enterprise Value | 102M 87.98M 80.89M 76.13M 143M 9.62B 144M 959M 373M 4.72B 383M 375M 16.34B | EV / Sales 2026 * |
1.28x | EV / Sales 2027 * | 0.76x |
| Free-Float |
77.21% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Fortress Biotech, Inc.
| 1 day | -0.98% | ||
| 1 week | +10.87% | ||
| Current month | +9.29% | ||
| 1 month | +23.39% | ||
| 3 months | -3.16% | ||
| 6 months | -7.83% | ||
| Current year | -16.39% |
| 1 week | 2.73 |  | 3.16 |
| 1 month | 2.4 | | 3.16 |
| Current year | 2.18 | | 4.53 |
| 1 year | 1.7 | | 4.53 |
| 3 years | 1.24 | | 10.65 |
| 5 years | 1.24 | | 57.15 |
| 10 years | 1.24 | | 91.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 71 | 20/12/2013 | |
Xiao Qin Lu
DFI | Director of Finance/CFO | 51 | 22/02/2012 |
David Jin
DFI | Director of Finance/CFO | 36 | 16/08/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Jimmie Harvey
BRD | Director/Board Member | 74 | 01/12/2008 |
| Chairman | 71 | 20/12/2013 | |
J. Lobell
BRD | Director/Board Member | 63 | 01/06/2006 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 04-01 | Free | Chief Financial Officer | 2,967 | 0.0096% | ||
| 03-18 | Free | Chief Executive Officer | 475,424 | 1.5318% | ||
| 03-18 | Free | Director | 475,424 | 1.5318% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.98% | +10.87% | +69.06% | -68.12% | 102M | |
| -0.36% | -0.82% | +18.08% | -22.37% | 61.85B | |
| -1.66% | -8.41% | +59.97% | +194.77% | 55.69B | |
| +2.78% | +37.00% | +37.00% | +37.00% | 41.88B | |
| +1.21% | +0.79% | -55.33% | -62.00% | 36.15B | |
| -1.16% | -0.96% | +56.51% | -32.59% | 29.33B | |
| -0.44% | +23.46% | +141.28% | -50.67% | 24.52B | |
| -1.77% | -9.66% | +42.68% | +57.75% | 19.78B | |
| +1.74% | +4.39% | -3.12% | +113.90% | 16.61B | |
| -0.02% | +0.82% | +56.96% | +102.75% | 16.2B | |
| Average | -0.06% | +5.28% | +42.31% | +27.04% | 30.21B | |
| Weighted average by Cap. | -0.02% | +3.63% | +35.92% | +37.29% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 79.88M 68.91M 63.35M 59.63M 112M 7.54B 113M 751M 292M 3.7B 300M 293M 12.8B | 134M 116M 106M 100M 188M 12.66B 190M 1.26B 491M 6.21B 503M 493M 21.49B |
| Net income | 90.51M 78.08M 71.79M 67.57M 127M 8.54B 128M 851M 331M 4.19B 340M 332M 14.5B | 21.13M 18.23M 16.76M 15.78M 29.64M 1.99B 29.89M 199M 77.33M 979M 79.31M 77.61M 3.39B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/06/26 | 3.060 $ | -0.33% | 43,714 |
| 17/06/26 | 3.070 $ | +4.78% | 689,378 |
| 16/06/26 | 2.930 $ | +2.45% | 375,026 |
| 15/06/26 | 2.860 $ | +3.25% | 463,991 |
| 12/06/26 | 2.770 $ | +0.36% | 286,074 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- FBIO Stock
Select your edition
All financial news and data tailored to specific country editions
